Activation of δ-Opioid Receptors Inhibits Neuronal-Like Calcium Channels and Distal Steps of Ca2+-Dependent Secretion in Human Small-Cell Lung Carcinoma Cells
Human lung
μ-opioid receptor
DOI:
10.1523/jneurosci.16-11-03672.1996
Publication Date:
2018-04-03T22:35:16Z
AUTHORS (8)
ABSTRACT
Human small-cell lung carcinoma (SCLC) cells express neuronal-like voltage-operated calcium channels (VOCCs) and release mitogenic hormones such as serotonin (5-HT). Opioid peptides, on the other hand, have been shown to reduce SCLC cell proliferation by an effective autocrine pathway. Here we show that in GLC8 cells, only delta-opioid receptor subtype mRNA is expressed. Consistently, selective agonist [D-Pen2-Pen5]-enkephalin (DPDPE), but not mu kappa agonists, potently dose-dependently inhibits high-threshold (HVA) VOCCs these cells. As peripheral neurons, this modulation largely voltage-dependent, mediated pertussis toxin (PTX)-sensitive G-proteins, cAMP-independent, mainly affecting N-type VOCCs. With same potency selectivity, DPDPE also antagonizes Ca(2+)-dependent of [3H]serotonin ([3H]5-HT) from However, depolarization-induced release, secretion induced thapsigargin or ionomycin. This suggests besides inhibiting HVA VOCCs, opioids exert a direct depressive action secretory apparatus latter effect PTX-sensitive G-protein but, contrary VOCC inhibition, it can be reversed elevations cAMP levels. These results for first time effectively depress both Ca2+ influx hormone using multiple modulatory pathways. It speculated two mechanisms may contribute opioid antimitogenic neuroendocrine
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (24)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....